Advances in minimally invasive treatment of upper gastrointestinal bleeding in liver cirrhosis
10.3969/j.issn.1001-5256.2023.02.028
- VernacularTitle:肝硬化上消化道出血的微创治疗进展
- Author:
Min XU
1
;
Yu NI
1
;
Rui ZHANG
1
;
Xiaobing WANG
1
;
Yuan HUANG
2
Author Information
1. Department of Gastroenterology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
2. Department of Hepatobiliary Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China
- Publication Type:Review
- Keywords:
Liver Cirrhosis;
Hemorrhage;
Minimally Invasive Surgical Procedures
- From:
Journal of Clinical Hepatology
2023;39(2):424-431
- CountryChina
- Language:Chinese
-
Abstract:
Liver cirrhosis is a common chronic liver disease in clinical practice, and the main causes of this disease include virus, alcohol, and immunity. Patients may experience a variety of complications in the late stage of liver cirrhosis, including upper gastrointestinal bleeding, hepatic encephalopathy, hepatorenal syndrome, and liver cancer, among which upper gastrointestinal bleeding is the main cause of death, and therefore, the control and prevention of upper gastrointestinal bleeding caused by liver cirrhosis is the key to reducing mortality rate and prolonging survival time. This article summarizes the commonly used minimally invasive methods for the treatment of upper gastrointestinal bleeding in liver cirrhosis and analyzes the indications for different treatment methods and related advances, so as to provide a reference for clinicians to choose the most suitable treatment regimen for the patient, thereby improving the survival rate of patients.
